Healthcare organizations are moving toward value-based care and increasingly adopting population health programs. Doing so requires a whole new mindset – specifically when thinking about prescription drugs.
A recent survey conducted by HealthLeaders Media shows that healthcare executives think their organizations are ready to take on the risk that is part and parcel of so many value-based care arrangements. Indeed, 73% of 101 healthcare leaders who participated in the survey said they are “very” or “somewhat” prepared to manage additional risk.
Healthcare providers are accustomed to taking things one day at a time. A patient comes in – and they deal with the presenting ailment and then move on. Under value-based care models, however, they need to look beyond the present and understand a patient’s future, in terms of clinical and financial risk.
Brokers and consultants often are left to rely on the same set of data (over and over again) when trying to enable clients to improve members’ health as their own financial health. As a result, consultants often find themselves frustrated when they can’t move the needle toward better results.